RAN and amyotrophic lateral sclerosis: Accordingly, and distinct from FXS, abnormal epigenetic modifications are thought to play a neuro-protective role in C9-related ALS-FTD by restricting the gain-of-function mechanisms (RNA and RAN-translation products) that are elicited by the mutation [32,34].